How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.

B cells T cells adaptive immunity aging immunosenescence vaccines

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Aug 2022
Historique:
received: 05 08 2022
revised: 22 08 2022
accepted: 24 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

The number of people that are 65 years old or older has been increasing due to the improvement in medicine and public health. However, this trend is not accompanied by an increase in quality of life, and this population is vulnerable to most illnesses, especially to infectious diseases. Vaccination is the best strategy to prevent this fact, but older people present a less efficient response, as their immune system is weaker due mainly to a phenomenon known as immunosenescence. The adaptive immune system is constituted by two types of lymphocytes, T and B cells, and the function and fitness of these cell populations are affected during ageing. Here, we review the impact of ageing on T and B cells and discuss the approaches that have been described or proposed to modulate and reverse the decline of the ageing adaptive immune system.

Identifiants

pubmed: 36077216
pii: ijms23179797
doi: 10.3390/ijms23179797
pmc: PMC9456031
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Spanish Association against Cancer (AECC)
ID : PROYE16001ESCO
Organisme : Instituto de Salud Carlos III (ISCIII)
ID : FEDER project grants (FIS PI17/02119, FIS PI20/00010, COV20/00000, and TRANSPOCART ICI19/00069)
Organisme : Biomedicine Project grant from the Department of Health of the Government of Navarre
ID : BMED 050-2019
Organisme : Department of Industry, Government of Navarre
ID : Strategic projects from the Department of Industry, Government of Navarre (AGATA, Ref 0011-1411-2020-000013; LINTERNA, Ref. 0011-1411-2020-000033; DESCARTHES, 0011-1411-2019-000058)
Organisme : Ministerio de Ciencia e Innovación
ID : PID2019-108989RB-I00, PLEC2021-008094 MCIN/AEI/10.13039/ 501100011033
Organisme : European Project Horizon 2020 Improved Vaccination for Older Adults
ID : ISOLDA; Grant agreement ID: 848166

Références

Nat Med. 2003 Jun;9(6):729-35
pubmed: 12766765
J Virol. 2009 Apr;83(7):3094-103
pubmed: 19176629
J Infect Dis. 2010 Apr 1;201(7):1024-30
pubmed: 20170376
Gerontology. 2002 Mar-Apr;48(2):62-71
pubmed: 11867927
Organogenesis. 2015;11(4):159-72
pubmed: 26588595
JAMA. 1994 Mar 2;271(9):698-702
pubmed: 8309034
Nat Med. 2012 Oct;18(10):1518-24
pubmed: 23023500
Nature. 2021 Aug;596(7872):417-422
pubmed: 34192737
Interdiscip Top Gerontol Geriatr. 2020;43:36-55
pubmed: 32294651
EMBO Rep. 2022 Feb 3;23(3):e53302
pubmed: 35037711
J Clin Invest. 2015 Dec;125(12):4666-80
pubmed: 26551682
Aging Cell. 2015 Jun;14(3):309-21
pubmed: 25720438
Nat Rev Drug Discov. 2021 Jun;20(6):454-475
pubmed: 33824489
Hum Vaccin Immunother. 2013 Apr;9(4):907-10
pubmed: 23319202
Front Immunol. 2021 May 27;12:673061
pubmed: 34122431
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
Curr Opin Immunol. 2009 Aug;21(4):440-5
pubmed: 19535233
Immunology. 2011 Sep;134(1):17-32
pubmed: 21711350
Semin Immunol. 2018 Oct;39:14-21
pubmed: 29801750
Free Radic Res. 2008 Mar;42(3):272-80
pubmed: 18344122
Curr Opin Immunol. 2005 Oct;17(5):486-91
pubmed: 16061371
Sci Rep. 2016 Feb 10;6:20686
pubmed: 26861911
Front Immunol. 2018 Aug 27;9:1931
pubmed: 30210492
Genes Cells. 2019 Dec;24(12):801-813
pubmed: 31621149
Front Aging. 2021 Aug 10;2:719342
pubmed: 35822004
Maturitas. 2011 Apr;68(4):322-30
pubmed: 21316879
Stem Cell Res Ther. 2011 Aug 11;2(4):34
pubmed: 21861858
Geroscience. 2017 Jun;39(3):261-271
pubmed: 28624868
Immunology. 2012 Jan;135(1):19-26
pubmed: 22044118
mBio. 2020 Sep 18;11(5):
pubmed: 32948688
Eur J Immunol. 2015 May;45(5):1441-51
pubmed: 25707450
Front Cell Dev Biol. 2019 Oct 02;7:213
pubmed: 31632966
Am J Transplant. 2022 May;22(5):1475-1482
pubmed: 35038362
Front Physiol. 2021 Jan 12;11:571416
pubmed: 33510644
Clin Exp Immunol. 2014 Apr;176(1):1-10
pubmed: 24313320
Mediators Inflamm. 2014;2014:973986
pubmed: 25214721
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E879-88
pubmed: 22434910
Eur J Immunol. 2005 Feb;35(2):622-31
pubmed: 15668924
Trends Mol Med. 2016 Aug;22(8):671-686
pubmed: 27395769
Cell Rep. 2016 Feb 9;14(5):1218-1231
pubmed: 26832412
Cytometry A. 2023 Feb;103(2):127-135
pubmed: 34125495
Front Immunol. 2021 Nov 23;12:780897
pubmed: 34887868
J Immunol. 2009 Apr 1;182(7):4237-43
pubmed: 19299722
Immun Ageing. 2019 Sep 13;16:25
pubmed: 31528180
EMBO Mol Med. 2010 Oct;2(10):415-27
pubmed: 20878914
Sci Rep. 2016 Apr 25;6:25051
pubmed: 27109638
Front Immunol. 2021 Aug 13;12:707830
pubmed: 34484207
Sci Transl Med. 2016 Mar 30;8(332):332ra46
pubmed: 27030598
Clin Sci (Lond). 2018 Sep 5;132(17):1925-1935
pubmed: 30185614
Mucosal Immunol. 2014 Jan;7(1):89-100
pubmed: 23715172
Aging Cell. 2018 Feb;17(1):
pubmed: 29024417
Nat Rev Immunol. 2014 Jan;14(1):24-35
pubmed: 24336101
Nat Immunol. 2022 Feb;23(2):186-193
pubmed: 35105982
Antioxid Redox Signal. 2011 Apr 15;14(8):1551-85
pubmed: 20812785
J Immunol. 2015 Sep 1;195(5):2134-40
pubmed: 26223652
Front Immunol. 2017 Aug 15;8:982
pubmed: 28861086
J Immunol. 2002 Jun 1;168(11):5893-9
pubmed: 12023394
N Engl J Med. 2015 May 28;372(22):2087-96
pubmed: 25916341
Immunology. 2014 Jan;141(1):1-8
pubmed: 23991647
Immunol Rev. 2019 Sep;291(1):154-173
pubmed: 31402502
Expert Rev Clin Immunol. 2022 Sep;18(9):961-981
pubmed: 35876758
FASEB J. 2018 May 21;:fj201800059R
pubmed: 29782203
Nat Immunol. 2020 Jun;21(6):684-694
pubmed: 32231301
Immunity. 2018 Feb 20;48(2):214-226
pubmed: 29466754
J Allergy Clin Immunol. 2020 May;145(5):1323-1331
pubmed: 32386656
Annu Rev Cell Dev Biol. 2020 Oct 6;36:551-574
pubmed: 33021823
J Infect Dis. 2004 Oct 1;190(7):1286-94
pubmed: 15346340
PLoS One. 2015 Mar 27;10(3):e0122282
pubmed: 25816015
Semin Immunol. 2018 Dec;40:83-94
pubmed: 30501873
J Immunol. 2022 Feb 1;208(3):562-570
pubmed: 35031578
Nat Aging. 2021 Sep;1(9):769-782
pubmed: 34746804
Science. 2002 Dec 13;298(5601):2199-202
pubmed: 12481138
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
Nat Rev Immunol. 2008 Jul;8(7):512-22
pubmed: 18469829
Clin Infect Dis. 2020 Nov 19;71(16):2150-2157
pubmed: 32442287
Exerc Immunol Rev. 2018;24:72-84
pubmed: 29461967
J Exp Med. 2008 Mar 17;205(3):711-23
pubmed: 18332179
J Allergy Clin Immunol. 2018 Sep;142(3):844-856
pubmed: 29155150
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S72-S80
pubmed: 35439286
Exp Gerontol. 2018 Jul 1;107:161-168
pubmed: 29038026
Front Immunol. 2020 Nov 11;11:585168
pubmed: 33262764
Curr Opin Immunol. 2014 Aug;29:38-42
pubmed: 24769424
Immun Ageing. 2011 Nov 15;8(1):11
pubmed: 22082184
Cell Immunol. 2020 Feb;348:104024
pubmed: 31843200
Nat Rev Immunol. 2011 Apr;11(4):289-95
pubmed: 21436838
Med Microbiol Immunol. 2019 Aug;208(3-4):263-269
pubmed: 31004198
Epigenomics. 2017 Apr;9(4):429-445
pubmed: 28322571
Semin Immunol. 2012 Oct;24(5):365-72
pubmed: 22560928
Cell Commun Signal. 2014 Jan 09;12:2
pubmed: 24405902
Age (Dordr). 2014 Feb;36(1):313-51
pubmed: 23877171
Immunity. 2015 Dec 15;43(6):1186-98
pubmed: 26682988
Exp Gerontol. 2013 Dec;48(12):1379-86
pubmed: 24055797
Vaccine. 2022 May 11;40(22):2999-3008
pubmed: 35459556
Blood. 2015 Apr 16;125(16):2507-18
pubmed: 25733583
Int J Mol Sci. 2022 Aug 31;23(17):
pubmed: 36077278
Expert Rev Vaccines. 2013 Jan;12(1):13-30
pubmed: 23256736
Trends Immunol. 2015 Dec;36(12):815-824
pubmed: 26611154
Ageing Res Rev. 2017 Jul;36:125-136
pubmed: 28396185
Nat Commun. 2020 Feb 6;11(1):751
pubmed: 32029736
Sci Transl Med. 2021 Mar 31;13(587):
pubmed: 33790024
Infect Dis (Lond). 2016;48(6):436-42
pubmed: 27030916
Front Immunol. 2016 Feb 25;7:41
pubmed: 26941738
Sci Immunol. 2021 Jun 18;6(60):
pubmed: 34145066
Can J Microbiol. 2021 Jan;67(1):23-28
pubmed: 32640169
Science. 2013 Oct 11;342(6155):1242454
pubmed: 24115444
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Br J Nutr. 2012 Dec 14;108(11):2054-65
pubmed: 22397808
J Infect. 2017 Nov;75(5):381-394
pubmed: 28935236
Ageing Res Rev. 2011 Jul;10(3):370-8
pubmed: 20933612
Vaccine. 2014 May 1;32(21):2507-17
pubmed: 24120672
Mol Cell. 2019 Oct 3;76(1):110-125.e9
pubmed: 31474573
PLoS Pathog. 2008 Sep 19;4(9):e1000159
pubmed: 18802458
Aging Cell. 2022 Jan;21(1):e13525
pubmed: 34962049
Curr Opin Pharmacol. 2018 Aug;41:34-41
pubmed: 29677646
Lancet Reg Health Eur. 2021 Nov;10:100208
pubmed: 34514454
Clin Infect Dis. 2015 Dec 15;61(12):1835-8
pubmed: 26265498
Exp Gerontol. 2007 May;42(5):400-6
pubmed: 17218073
Nat Med. 2018 Jul;24(7):978-985
pubmed: 29942094
Nat Rev Immunol. 2021 Feb;21(2):83-100
pubmed: 33353987
Nat Rev Immunol. 2010 Aug;10(8):594-604
pubmed: 20651746
Rejuvenation Res. 2012 Oct;15(5):507-15
pubmed: 22950432
Immun Ageing. 2009 Jun 12;6:9
pubmed: 19523191
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
Nat Immunol. 2014 Oct;15(10):965-72
pubmed: 25151490
Clin Vaccine Immunol. 2014 Apr;21(4):570-9
pubmed: 24521786
Cell Immunol. 1991 Jun;135(1):118-31
pubmed: 1826862
Immun Ageing. 2020 Jan 20;17:2
pubmed: 31988649
Immun Ageing. 2013 May 16;10(1):20
pubmed: 23680476
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
Ann N Y Acad Sci. 2007 Apr;1100:98-110
pubmed: 17460168
Eur J Immunol. 2019 Oct;49(10):1457-1973
pubmed: 31633216
Aging Cell. 2017 Apr;16(2):293-303
pubmed: 28026094
Nat Immunol. 2017 Mar;18(3):354-363
pubmed: 28114291
Exp Gerontol. 2007 May;42(5):416-20
pubmed: 17182206
Clin Immunol. 2008 Apr;127(1):107-18
pubmed: 18222733
Semin Immunol. 2012 Oct;24(5):350-5
pubmed: 22564707
Curr Pharm Des. 2010;16(6):609-18
pubmed: 20388071
J Clin Invest. 2014 Sep;124(9):4004-16
pubmed: 25083993
Immun Ageing. 2020 Nov 19;17(1):37
pubmed: 33292323
Rev Med Virol. 2020 Sep;30(5):e2144
pubmed: 32671966
Sci Rep. 2017 Jan 16;7:40312
pubmed: 28091576
Sci Transl Med. 2015 Apr 1;7(281):281ra43
pubmed: 25834109
Front Immunol. 2021 Nov 16;12:778679
pubmed: 34868051
Vaccine. 2014 Mar 26;32(15):1745-53
pubmed: 24508036
Ann N Y Acad Sci. 2006 Nov;1089:487-95
pubmed: 17261791
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
Eur J Immunol. 2016 Oct;46(10):2286-2301
pubmed: 27595500
Nat Rev Drug Discov. 2010 Apr;9(4):293-307
pubmed: 20380038
Hum Vaccin Immunother. 2014;10(5):1181-6
pubmed: 24614530
Cytotherapy. 2015 May;17(5):613-20
pubmed: 25747742
Immunol Cell Biol. 2019 Aug;97(7):675-684
pubmed: 31140625
Clin Exp Immunol. 2016 Jan;183(1):50-6
pubmed: 26332693
Front Immunol. 2021 Sep 29;12:743422
pubmed: 34659239
J Immunol. 2005 Sep 1;175(5):3262-7
pubmed: 16116217
Aging Cell. 2019 Aug;18(4):e12959
pubmed: 31056853
Cancers (Basel). 2016 Mar 15;8(3):
pubmed: 26999211
Sci Transl Med. 2014 Dec 24;6(268):268ra179
pubmed: 25540326
Clin Immunol. 2020 Aug;217:108486
pubmed: 32479985
Front Immunol. 2019 Sep 25;10:2247
pubmed: 31608061
Int J Mol Sci. 2020 Sep 05;21(18):
pubmed: 32899486
Expert Rev Vaccines. 2007 Jun;6(3):441-56
pubmed: 17542758
AIMS Public Health. 2021 May 8;8(3):388-415
pubmed: 34395690
Immun Ageing. 2018 Jan 22;15:3
pubmed: 29387135
Front Immunol. 2012 Oct 10;3:302
pubmed: 23087687
Biogerontology. 2016 Feb;17(1):7-19
pubmed: 25921609
Trends Mol Med. 2013 Jun;19(6):355-67
pubmed: 23601906

Auteurs

Maider Garnica (M)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Anna Aiello (A)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Mattia Emanuela Ligotti (ME)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Giulia Accardi (G)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Hugo Arasanz (H)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Ana Bocanegra (A)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Ester Blanco (E)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Division of Gene Therapy and Regulation of Gene Expression, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Anna Calabrò (A)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Luisa Chocarro (L)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Miriam Echaide (M)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Grazyna Kochan (G)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Leticia Fernandez-Rubio (L)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Pablo Ramos (P)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Fanny Pojero (F)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Nahid Zareian (N)

The Rayne Institute, School of Cancer and Pharmaceutical Sciences, King's College London, London WC2R 2LS, UK.

Sergio Piñeiro-Hermida (S)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Farzin Farzaneh (F)

The Rayne Institute, School of Cancer and Pharmaceutical Sciences, King's College London, London WC2R 2LS, UK.

Giuseppina Candore (G)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

Calogero Caruso (C)

Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy.

David Escors (D)

Oncoimmunology Group, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH